Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?

The review discusses the problem of anticoagulant therapy for the prevention of stroke and systemic embolism in patients with atrial fibrillation and comorbidities (hypertension, heart defects, including after heart valve surgery, coronary artery disease, diabetes mellitus, chronic kidney disease, g...

Full description

Bibliographic Details
Main Authors:	E V Schlyakhto, E I Baranova, V A Ionin
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-01-01
Series:	Российский кардиологический журнал
Subjects:	atrial fibrillation anticoagulants comorbidity
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4801

Similar Items

THE SELECTION PROBLEMS OF ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION WITH COMORBIDITIES
by: N. A. Koziolova, et al.
Published: (2015-08-01)

Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban
by: O. L. Barbarash, et al.
Published: (2020-11-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
by: A. G. Obrezan, et al.
Published: (2021-06-01)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
by: Runkai Li, et al.
Published: (2023-05-01)

ATRIAL FIBRILLATION AND HEART FAILURE: APPROACHES TO ANTITHROMBOTIC THERAPY
by: B. A. Tatarsky, et al.
Published: (2017-08-01)

HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION?
by: E. I. Baranova, et al.
Published: (2017-11-01)

A patient with atrial fibrillation and comorbidities in clinical practice
by: A. S. Skotnikov, et al.
Published: (2020-12-01)

Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function
by: N. V. Drobotya, et al.
Published: (2020-05-01)

Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation
by: Frederik Dalgaard, et al.
Published: (2020-12-01)

THE APPROPRIATENESS OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: A. Y. RYCHKOV, et al.
Published: (2016-12-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

Comorbidity patterns and mortality in atrial fibrillation: a latent class analysis of the EURopean study of Older Subjects with Atrial Fibrillation (EUROSAF)
by: Huah Shin Ng, et al.
Published: (2025-12-01)

Anticoagulant therapy and components of the metabolic syndrome in patients with atrial fibrillation in real outpatient clinical practice
by: V. A. Ionin, et al.
Published: (2019-04-01)

Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness”
by: S. V. Malchikova, et al.
Published: (2019-10-01)

ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

Analysis of the consumption volumes of antithrombotic drugs used for pharmacotherapy of atrial fibrillation in Saratov Region
by: А. V. Sokolov, et al.
Published: (2022-01-01)

Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure
by: Kotaro Nochioka, et al.
Published: (2022-08-01)

Practical aspects of antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Zh. D. Kobalava, et al.
Published: (2021-10-01)

Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
by: Shin‐Yi Lin, et al.
Published: (2022-03-01)

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
by: E. I. Baranova, et al.
Published: (2020-02-01)

Prevalence of Valvular and Non-valvular Atrial Fibrillation and the Application of Antithrombotic Treatment in a Tertiary Care Hospital
by: Sahadeb Prasad Dhungana, et al.
Published: (2020-11-01)

THE EVALUATION OF ANTITHROMBOTIC TREATMENT PRESCRIPTION DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION BY THE DATA OF PROFILE REGISTRY
by: S. Yu. Martsevich, et al.
Published: (2015-02-01)

Changes in prescribing antithrombotic therapy in patients with atrial fibrillation and myocardial infarction in 2016-2019
by: K. G. Pereverzeva, et al.
Published: (2020-08-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
by: E. I. Baranova
Published: (2018-11-01)

Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death
by: Hanne Ehrlinder, et al.
Published: (2022-10-01)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
by: Darae Ko, et al.
Published: (2021-11-01)

Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020
by: A. S. Gerasimenko, et al.
Published: (2022-01-01)

Resumption of anticoagulant therapy after major bleeding and the risk of negative events in patients with atrial fibrillation (based on REGistry of Long-term AnTithrombotic TherApy-2 – REGATA)
by: Ekaterina S. Kropacheva, et al.
Published: (2023-01-01)

Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

Atrial Fibrillation Burden: Impact on Stroke Risk and Beyond
by: Ahmed AlTurki, et al.
Published: (2024-03-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Antithrombotic Therapy in Elderly Patients with Atrial Fibrillation: The State of the Problem in the Real Clinical Practice of a Family Medicine Doctor
by: Bazira Kanat кyzy, et al.
Published: (2021-06-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

Renal Function Protection as an Important Component of a Comprehensive Approach to the Management of Patients with Atrial Fibrillation
by: T. V. Pavlova
Published: (2022-01-01)

Reasons for not prescribing anticoagulants in hospitalized patients with atrial fibrillation and high risk of stroke: what should be the optimal management tactics for these patients?
by: E. I. Baranova, et al.
Published: (2022-07-01)

Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
by: Josef Finsterer, et al.
Published: (2012-02-01)

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry
by: Xiaoxia Liu, et al.
Published: (2023-08-01)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
by: So-Ryoung Lee, et al.
Published: (2022-08-01)